T1	Participants 408 508	3445 patients with symptomatic heart failure and a left ventricular ejection fraction of 45% or more
T2	Participants 1769 1830	patients with heart failure and a preserved ejection fraction
T3	Participants 268 346	patients with heart failure and a preserved left ventricular ejection fraction
